IDH1 and central nervous system cancer: In recent years, the World Health Organization (WHO) has classified gliomas into grades I to IV [2,3], with the 2021 classification emphasizing genetic differences by distinguishing between grade IV astrocytoma and isocitrate-dehydrogenase (IDH)-wildtype glioblastoma [3].